Cheap and deadly: Inside Canada’s opioid crisis

President Trump scheduled a major briefing on the epidemic of opiod drug use and said his administration will fight it and 'will win'.

France 24 journalists meet eyewitnesses (Observers) to discuss memorable events they have experienced.

Today’s Focus report takes us to Cameroon where we look at a growing addiction to opioids. Readily available on the black market, one of the most abused substances, Tramadol, is now making its way into schoolyards.

Opioid crisis: Purdue Pharma pays $270 million in historic settlement.

Oklahoma's Attorney General accused Johnson & Johnson of a "multi-billion-dollar brainwashing campaign" to get doctors to overprescribe opioids, downplaying the addiction risks. J&J shares surged after the ruling.

US population decimated by opioid overdoses

Purdue Pharma LP opened its first day in bankruptcy court by pledging to continue investigating whether its owners, the Sackler family, who are accused of spurring America’s opioid epidemic, wrongly took cash out of the pharmaceutical maker. Bloomberg's Tom Metcalf and Lisa Abramowicz speak on "Bloomberg's Money Undercover" about the Sacklers.

US opioid crisis: Pharmaceutical giants reach deal to avoid lawsuit

In Mexico, poppy farming and the production of opium paste – heroin's main ingredient – have long been the main source of revenue for many impoverished rural communities. But this is no longer the case, with both organised crime and addicts now turning to fentanyl – a cheap, ultraconcentrated and synthetic opioid – as their drug of choice. Our Mexico correspondents Laurence Cuvillier and Matthieu Comin report from Guerrero State, where a rural exodus is underway.

The civil suit brought forward by the DOJ accuses Walmart of knowingly filling thousands of invalid prescriptions. The retailer says it is in a no-win situation and wants the suit thrown out.

McKinsey & Company, the consultant to blue-chip corporations and governments around the world, has agreed to pay $573 million to settle investigations into its role in helping “turbocharge” opioid sales, a rare instance of it being held publicly accountable for its work with clients.

Four drugs companies in the United States have agreed to pay up to $26 billion to settle claims that they fuelled an opioid addiction crisis in the country. The deal was unveiled by a group of state attorneys general and could settle thousands of cases over the epidemic. Opioid addiction is estimated to have claimed over one million lives in the US. Individual states and local governments will now have to sign up to the deal, but there are divisions over how the payout will be shared.